Katherine Louise Musliner

Katherine Louise Musliner

Auto-generated profile, based on publicly available information

Katherine Louise Musliner

Department of Affective Disorders, Aarhus University Hospital

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Journal of Affective Disorders
Verified
Journal Article
Closed access
KMKatherine L. Musliner
Katherine L. Musliner
TMTrine Munk-Olsen
Trine Munk-Olsen
WEWilliam W. Eaton
William W. Eaton
PZPeter P. Zandi
Peter P. Zandi

1 March 2016 in Journal of Affective Disorders
Verified
Journal Article
Closed access
TLThomas Munk Laursen
Thomas Munk Laursen
KMKatherine L. Musliner
Katherine L. Musliner
MBMichael Eriksen Benros
Michael Eriksen Benros
MVMogens Vestergaard
Mogens Vestergaard
TMTrine Munk-Olsen
Trine Munk-Olsen

9 December 2014 in Psychological Medicine
Verified
Journal Article
Closed access
PDF file
KMK. L. Musliner
K. L. Musliner
FSF. Seifuddin
F. Seifuddin
JJJ. A. Judy
J. A. Judy
Mehdi PiroozniaMehdi Pirooznia
Mehdi Pirooznia
FGF. S. Goes
F. S. Goes
PZP. P. Zandi
P. P. Zandi
Background.: Previous studies suggest that the relationship between genetic risk and depression may be moderated by stressful life events (SLEs). The goal of this study was to assess whether SLEs moderate the association between polygenic risk of major depressive disorder (MDD) and depressive symptoms in older adults.Method.: We used logistic and negative binomial regressions to assess the associations between polygenic risk, SLEs and depressive symptoms in a sample of 8761 participants from the Health and Retirement Study. Polygenic scores were derived from the Psychiatric Genomics Consortium genome-wide association study of MDD. SLEs were operationalized as a dichotomous variable indicating whether participants had experienced at least one stressful event during the previous 2 years. Depressive symptoms were measured using an eight-item Center for Epidemiologic Studies Depression Scale subscale and operationalized as both a dichotomous and a count variable.Results.: The odds of reporting four or more depressive symptoms were over twice as high among individuals who experienced at least one SLE (odds ratio 2.19, 95% confidence interval 1.86–2.58). Polygenic scores were significantly associated with depressive symptoms (β= 0.21,p⩽ 0.0001), although the variance explained was modest (pseudor2= 0.0095). None of the interaction terms for polygenic scores and SLEs was statistically significant.Conclusions.: Polygenic risk and SLEs are robust, independent predictors of depressive symptoms in older adults. Consistent with an additive model, we found no evidence that SLEs moderated the association between common variant polygenic risk and depressive symptoms.


1 May 2019 in JAMA Psychiatry
Verified
Journal Article
Closed access
PDF file
KMKatherine L. Musliner
Katherine L. Musliner
PMPreben B. Mortensen
Preben B. Mortensen
JMJohn J. McGrath
John J. McGrath
NSNis P. Suppli
Nis P. Suppli
DHDavid M. Hougaard
David M. Hougaard
FCfor the Bipolar Disorder Working Group of the Psychiatric Genomics Consortium
for the Bipolar Disorder Working Group of the Psychiatric Genomics Consortium
Importance Although the usefulness of polygenic risk scores as a measure of genetic liability for major depression (MD) has been established, their association with depression in the general population remains relatively unexplored. Objective To evaluate whether polygenic risk scores for MD, bipolar disorder (BD), and schizophrenia (SZ) are associated with depression in the general population and explore whether these polygenic liabilities are associated with heterogeneity in terms of age at onset and severity at the initial depression diagnosis. Design, Setting, and Participants Participants were drawn from the Danish iPSYCH2012 case-cohort study, a representative sample drawn from the population of Denmark born between May 1, 1981, and December 31, 2005. The hazard of depression was estimated using Cox regressions modified to accommodate the case-cohort design. Case-only analyses were conducted using linear and multinomial regressions. The data analysis was conducted from February 2017 to June 2018. Exposures Polygenic risk scores for MD, BD, and SZ trained using the most recent genome-wide association study results from the Psychiatric Genomics Consortium. Main Outcomes and Measures The main outcome was first depressive episode (International Statistical Classification of Diseases and Related Health Problems, Tenth Revision [ICD-10] code F32) treated in hospital-based psychiatric care. Severity at the initial diagnosis was measured using theICD-10code severity specifications (mild, moderate, severe without psychosis, and severe with psychosis) and treatment setting (inpatient, outpatient, and emergency). Results Of 34 573 participants aged 10 to 31 years at censoring, 68% of those with depression were female compared with 48.9% of participants without depression. Each SD increase in polygenic liability for MD, BD, and SZ was associated with 30% (hazard ratio [HR], 1.30; 95% CI, 1.27-1.33), 5% (HR, 1.05; 95% CI, 1.02-1.07), and 12% (HR, 1.12; 95% CI, 1.09-1.15) increases in the hazard of depression, respectively. Among cases, a higher polygenic liability for BD was associated with earlier depression onset (β = −.07; SE = .02;P = .002). Conclusions and Relevance Polygenic liability for MD is associated with first depression in the general population, which supports the idea that these scores tap into an underlying liability for developing the disorder. The fact that polygenic risk for BD and polygenic risk for SZ also were associated with depression is consistent with prior evidence that these disorders share some common genetic overlap. Variations in polygenic liability may contribute slightly to heterogeneity in clinical presentation, but these associations appear minimal.

2 March 2018 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Closed access
PDF file
KMK. L. Musliner
K. L. Musliner
SØS. D. Østergaard
S. D. Østergaard